Vaxcyte (PCVX) Non Operating Investment Income (2024)

Vaxcyte's (PCVX) quarterly Non Operating Investment Income came in at $1000.0 in Q3 2024, down 96.3% on a QoQ basis from $27000.0 in Q2 2024.

Vaxcyte (PCVX) Non Operating Investment Income (2024) Analysis & Trends

Vaxcyte (PCVX) has 1 years of Non Operating Investment Income data on file, last reported at $1000.0 in Q3 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Investment Income (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Vaxcyte	7.76 Bn	7.76 Bn	-	-

Download Data